BTI Biotechnology Institute proposes a minimally invasive alternative for this surgical treatment: the new family of 3.0 implants
More and more scientific studies are revealing the predictability of immediate loaded short implants. Thus, the development by BTI® of a series of surgical-prosthetic concepts, resulting in a protocol that uses short implants, front cutting drills and Multi – Im® transepithelial abutments enables the execution, with better results, of the immediate loading technique in multiple restorations
BTI Biotechnology Institute is the pioneering company leading the market in the development of tissue regeneration techniques through the therapeutic use of plasma rich in growth factors.
With the aim of helping to solve compromised prosthetic situations, BTI brings its customers a New Line of Multi-Im® transepithelials abutments for implants with the Interna ® connection, with an angle of 30º between the prosthetic and surgical axes.
With the use of UNIT® Transepithelials, the advantages of BioBlock® concept can as well be achieved in single restorations.
New product for tissue regeneration that boosts skin volume in the treatment of wrinkles.
Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.